# EADA Business School

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/eada-business-school/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57 |
| Citations | 21,346 |
| City | Barcelona |
| Country | Spain |
| Description | EADA Business School is a research organisation in Barcelona, Spain. OpenAlex records 679 works and 21,346 citations for it. 1 researchers list it as their most recent affiliation. |
| Homepage | https://www.eada.edu |
| OpenAlex ID | https://openalex.org/I134033392 |
| Region | Catalonia |
| Researchers | 1 |
| ROR ID | https://ror.org/033qfx261 |
| Type | education |
| Works | 679 |

## University papers

- [Adjuvant Trastuzumab in HER2-Positive Breast Cancer](https://scholariq.org/papers/adjuvant-trastuzumab-in-her2-positive-breast-cancer/)
- [A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-letrozole-in-postmenopausal-women-after-five-years-of/)
- [RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer](https://scholariq.org/papers/ribbon-1-randomized-double-blind-placebo-controlled-phase-iii-trial-of/)
- [Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/neratinib-after-trastuzumab-based-adjuvant-therapy-in-her2-positive-breast/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)

## University researchers

- [Nicholas J. Robert](https://scholariq.org/researchers/nicholas-j-robert/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.